John R. Stuelpnagel - Oct 7, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol: TXG
Transactions as of: Oct 7, 2021
Transactions value $: -$750,899
Form type: 4
Date filed: 10/12/2021, 04:15 PM
Previous filing: Sep 20, 2021
Next filing: Oct 20, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Sale	-$751K	-5K	-1.35%	$150.18	367K	Oct 7, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2	This transaction was executed in multiple trades at prices ranging from $150.00 to $150.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Content

The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

This transaction was executed in multiple trades at prices ranging from $150.00 to $150.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.